Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-17

Clinical Trial Update: Randomized Trial of Suicide Gene Therapy and Prostate Cancer [Phase 2]

View source ↗

Summary

Completed Phase 2 randomized trial of suicide gene therapy for prostate cancer; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Henry Ford Health System | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-17